NEVVI Medicare utilization intelligence

Geography — Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, (G2083) in Medicare, the United States

Geography · G2083 · National · CY2024
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where G2083 is billed · every state marketincluded in Explore

Every state market that bills this code, by services, each linked to its own market page.